title: Immune therapies.
abstract: Immune cells with specific functions and abilities are vital to cancer treatment prevention. Although there have been many accomplishments made in the areas of immunotherapy and immunobiology of myeloma, there are still many obstacles in the way of conceptualizing the interrelationships between immune cells and tumor cells. To provide better understanding of these concepts and to move toward improved therapies for myeloma, cell-based therapeutic approaches should be developed.
authors.affiliation: Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Department of Medical Oncology, Harvard Medical School, Boston, MA 02115, USA.
authors.forename: Rao H
authors.initials: RH
authors.lastname: Prabhala
authors.forename: Nikhil C
authors.initials: NC
authors.lastname: Munshi
mesh_terms: D002450:Cell Communication / Q000276:immunology; D002986:Clinical Trials as Topic; D003713:Dendritic Cells / Q000276:immunology / Q000637:transplantation; D006801:Humans; D007130:Immunoglobulin Idiotypes / Q000276:immunology; D016233:Immunotherapy, Active / Q000379:methods*; D009101:Multiple Myeloma / Q000188:drug therapy / Q000276:immunology*
chemical_list: D007130:Immunoglobulin Idiotypes